Renaissance BioScience Corp. adds to senior executive team

Bioengineering technology company Renaissance BioScience Corp. has added a new member to its senior executive team to accelerate the commercialization of its RNA production and oral delivery platform technology.

S. Brad Griffith has more than 30 years’ experience in agriculture and life sciences, much of it at a senior executive level. He has worked for BioAg Alliance, a joint venture of Monsanto and Novozymes, and was most recently chief commercial officer at Kansas-based Compass Minerals.

“I am impressed by the innovation capabilities and IP of Renaissance BioScience and their potential to develop next-generation technologies that can help producers maximize economic returns more sustainably,” Griffith said. “I am excited to work with the Renaissance team to bring their technologies to industry. They are very open to partnerships and co-creation.”

Vancouver-based Renaissance BioScience Corp. develops market-ready microorganisms that provide solutions to environmental, health and industrial efficiency problems in industries including agriculture, food and beverage, animal and human health, and energy. Its technology has applications for agricultural crop protection and non-agriculture biocontrol.

“Brad’s industry knowledge, strategic vision and operational implementation capabilities are a perfect fit to maximize the extensive global commercial opportunities for valuable product creation in agricultural crop protection, animal health and biocontrol that the Renaissance RNA platform technology has application for,” said Maurice Boucher, Renaissance executive chair.

“Renaissance’s technology addresses the need for environmentally friendly agriculture technologies that are effective and affordable. With the help of experienced senior industry executives like Brad Griffith, we can make major contributions to the future of sustainable agriculture.”